SEC Form 4 · accession 0001209191-15-021214
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 3, 2015 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $97.40 | Mar 2, 2015 | A | 165,000 | A | — | Mar 2, 2025 | Common Stock | 165,000 | 165,000 | D |
Explanation of responses
- F1This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2016 and in 36 equal monthly installments thereafter.